MAPT and Atrophy: Interestingly we found a significant interaction between diagnosis and location (anterior vs. posterior atrophy) in both SCD and MCI with low Aβ42 or elevated P-tau levels when comparing these participants with CN with normal levels of the CSF biomarkers.